Blueprint Medicines
The Associate Director, International Supply Chain position at Blueprint Medicines in Munich involves leading external partnerships for packaging, serialization, and distribution of finished goods across multiple European markets. The role supports supply chain operational leadership, cross-functional collaboration, regulatory compliance, and project management to ensure product supply meets quality and regulatory standards.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2011
Blueprint Medicines is a biotechnology company focused on developing targeted therapies for patients with cancer and rare diseases. The company uses precision medicine and genomics to design drugs that selectively inhibit disease-causing proteins, particularly kinase-driven cancers and systemic mastocytosis.
Sanofi To Buy Blueprint Medicines For Up To $9.5B: Retail Sees More Acquisition Offers From European Pharma Companies
4 days ago
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis
2 weeks ago
Blueprint’s rare disease drug Ayvakit shows long-term benefit
1 week ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Blueprint Medicines.
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
Jun 2, 2025
Associate Director, Commercial Supply Chain
Revolution Medicines
Director, Drug Supply Chain Business Systems
Revolution Medicines
Director, Regional Supply Chain – EMEA
biomarin
Commercial Supply Chain Packaging Associate
Replimune
Associate Director Commercial Packaging and 3PL Inventory Management
Ocular Therapeutix
Associate Director, International Commercial Supply Planning
Mirum Pharmaceuticals